Journal
Journal of Lipid Research
Publication Date
4-1-2026
Volume
67
Issue
4
First Page
101013
Document Type
Open Access Publication
DOI
10.1016/j.jlr.2026.101013
Rights and Permissions
Hussain R, Raut C, Prabhu P, Irshaid A, Hegde Y, Chen Y, Pant A, Oliveri A, Wei X, Yin L, Russell TL, Halligan B, Semenkovich CF, Speliotes EK. LYPLAL1 rare loss-of-function variants in humans and deletion in human hepatoma cells protect against MASLD. J Lipid Res. 2026 Apr;67(4):101013. doi: 10.1016/j.jlr.2026.101013. © 2026 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Recommended Citation
Hussain, Rawdat; Raut, Chinmay; Prabhu, Ponnandy; Irshaid, Akram; Hegde, Yash; Chen, Yue; Pant, Asmita; Oliveri, Antonino; Wei, Xiaochao; Yin, Lishi; Russell, Tiffany L; Halligan, Brian; Semenkovich, Clay F; and Speliotes, Elizabeth K, "LYPLAL1 rare loss-of-function variants in humans and deletion in human hepatoma cells protect against MASLD." Journal of Lipid Research. 67, 4. 101013 (2026).
https://digitalcommons.wustl.edu/oa_4/6586
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
